Search

Your search keyword '"Irfan Rahman"' showing total 489 results

Search Constraints

Start Over You searched for: Author "Irfan Rahman" Remove constraint Author: "Irfan Rahman"
489 results on '"Irfan Rahman"'

Search Results

51. Pulmonary Toxicity and the Pathophysiology of Electronic Cigarette, or Vaping Product, Use Associated Lung Injury

52. Differences in Acellular Reactive Oxygen Species (ROS) Generation by E-Cigarettes Containing Synthetic Nicotine and Tobacco-Derived Nicotine

53. SARS-CoV2 Infection Alters Tryptophan Catabolism and Phospholipid Metabolism

54. Comparative Reactive Oxygen Species (ROS) Content among Various Flavored Disposable Vape Bars, including Cool (Iced) Flavored Bars

55. DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD

56. 4219 Discrepancies in flavor preferences among adult ever users of various tobacco products in the US – Findings from The Population Assessment of Tobacco and Health Study (2015-2016)

57. Small RNA-sequence analysis of plasma-derived extracellular vesicle miRNAs in smokers and patients with chronic obstructive pulmonary disease as circulating biomarkers

58. Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries

59. Waterpipe smoke and e-cigarette vapor differentially affect circadian molecular clock gene expression in mouse lungs.

60. Classification of flavors in cigarillos and little cigars and their variable cellular and acellular oxidative and cytotoxic responses.

61. Multi-Walled Carbon Nanotubes (MWCNTs) Cause Cellular Senescence in TGF-β Stimulated Lung Epithelial Cells

62. Dysregulated Metabolites Serve as Novel Biomarkers for Metabolic Diseases Caused by E-Cigarette Vaping and Cigarette Smoking

63. 4179 Use of tobacco products and their association with wheezing among adult current tobacco users in the US – Findings from The Population Assessment of Tobacco and Health Study (2015-2016)

64. Pulmonary Toxicity and Inflammatory Response of Vape Cartridges Containing Medium-Chain Triglycerides Oil and Vitamin E Acetate: Implications in the Pathogenesis of EVALI

65. Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)

66. Tobacco use and chemosensory impairments among current adult tobacco users in the US: Data from NHANES 2013–2014

67. Inhibition of RAGE Attenuates Cigarette Smoke-Induced Lung Epithelial Cell Damage via RAGE-Mediated Nrf2/DAMP Signaling

68. Inflammatory and Oxidative Responses Induced by Exposure to Commonly Used e-Cigarette Flavoring Chemicals and Flavored e-Liquids without Nicotine

69. Genetic ablation of CXCR2 protects against cigarette smoke-induced lung inflammation and injury

70. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives

71. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung.

72. Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis.

73. P21-PARP-1 pathway is involved in cigarette smoke-induced lung DNA damage and cellular senescence.

74. Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-κB-dependent genes.

75. NF-κB inducing kinase, NIK mediates cigarette smoke/TNFα-induced histone acetylation and inflammation through differential activation of IKKs.

76. Review: Antioxidant therapeutic advances in COPD

80. Pulmonary immune response regulation, genotoxicity, and metabolic reprogramming by menthol- and tobacco-flavored e-cigarette exposures in mice

81. Community and Stakeholder Participation in the Implementation of Corporate Social Responsibility Programs, Its Impact on Rural Communities

82. Circadian clock-based therapeutics in chronic pulmonary diseases

84. Vaping Greed: Perception, Social Media, Marketing, Public Health, and Toxicity

86. An evaluation of statistical differential analysis methods in single-cell RNA-seq data

87. Classification, Perception, Sociological Aspects, and Toxicity of Emerging Flavored Oral Nicotine Pouches

88. The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report

90. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment

91. NIH SenNet Consortium: Mapping Senescent Cells in the Human Body to Understand Health and Disease

92. Perfluorooctane Sulfonic Acid Disrupts Protective Tight Junction Proteins via Protein Kinase D in Airway Epithelial Cells

93. Potential Impact of the COVID-19 Pandemic on Public Perception of Water Pipes on Reddit: Observational Study (Preprint)

94. Flavor Classification/Categorization and Differential Toxicity of Oral Nicotine Pouches (ONPs) in Lung Epithelial Cells

95. Recent updates on biomarkers of exposure and systemic toxicity in e-cigarette users and EVALI

96. Environmental Exposures and Phenotype of Non-smoking COPD

97. Synthetic Coolant WS-23 increases E-Cigarette Generated Aerosolized Acellular Reactive Oxygen Species (ROS) Levels

98. Circadian Molecular Clock Disruption in Chronic Pulmonary Diseases

99. PERSEPSI SISWA PADA PEMBELAJARAN PENDIDIKAN JASMANI OLAHRAGA DAN KESEHATAN TINGKAT SMA

100. Association of flavored electronic nicotine delivery system (ENDS) use with self-reported chronic obstructive pulmonary disease (COPD): Results from the Population Assessment of Tobacco and Health (PATH) study, Wave 4

Catalog

Books, media, physical & digital resources